- Home
- NSSC vs NVAX Comparison
NSSC vs NVAX Comparison
Compare NSSC & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSSC
- NVAX
- Stock Information
- Founded
- NSSC 1969
- NVAX 1987
- Country
- NSSC United States
- NVAX United States
- Employees
- NSSC 1070
- NVAX N/A
- Industry
- NSSC Telecommunications Equipment
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NSSC Telecommunications
- NVAX Health Care
- Exchange
- NSSC Nasdaq
- NVAX Nasdaq
- Market Cap
- NSSC 1.5B
- NVAX 2.0B
- IPO Year
- NSSC N/A
- NVAX 1995
- Fundamental
- Price
- NSSC $39.12
- NVAX $9.76
- Analyst Decision
- NSSC Strong Buy
- NVAX Buy
- Analyst Count
- NSSC 6
- NVAX 6
- Target Price
- NSSC $55.33
- NVAX $17.83
- AVG Volume (30 Days)
- NSSC 350.1K
- NVAX 7.2M
- Earning Date
- NSSC 11-04-2024
- NVAX 11-07-2024
- Dividend Yield
- NSSC 1.27%
- NVAX N/A
- EPS Growth
- NSSC 83.56
- NVAX N/A
- EPS
- NSSC 1.34
- NVAX N/A
- Revenue
- NSSC $188,820,000.00
- NVAX $987,667,000.00
- Revenue This Year
- NSSC $14.19
- NVAX N/A
- Revenue Next Year
- NSSC $14.67
- NVAX N/A
- P/E Ratio
- NSSC $29.43
- NVAX N/A
- Revenue Growth
- NSSC 11.07
- NVAX N/A
- 52 Week Low
- NSSC $17.76
- NVAX $3.53
- 52 Week High
- NSSC $58.09
- NVAX $23.86
- Technical
- Relative Strength Index (RSI)
- NSSC 45.46
- NVAX 36.20
- Support Level
- NSSC $38.53
- NVAX $9.52
- Resistance Level
- NSSC $39.64
- NVAX $10.63
- Average True Range (ATR)
- NSSC 1.11
- NVAX 0.57
- MACD
- NSSC 0.03
- NVAX -0.12
- Stochastic Oscillator
- NSSC 35.31
- NVAX 9.97
About NSSC NAPCO Security Technologies Inc.
NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses.
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.